174 related articles for article (PubMed ID: 20183530)
1. Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity.
Ginsberg G; Neafsey P; Hattis D; Guyton KZ; Johns DO; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):473-507. PubMed ID: 20183530
[TBL] [Abstract][Full Text] [Related]
2. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
[TBL] [Abstract][Full Text] [Related]
3. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
[TBL] [Abstract][Full Text] [Related]
4. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
5. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms and activity of PON1 in a Mexican population.
Rojas-García AE; Solís-Heredia MJ; Piña-Guzmán B; Vega L; López-Carrillo L; Quintanilla-Vega B
Toxicol Appl Pharmacol; 2005 Jun; 205(3):282-9. PubMed ID: 15922013
[TBL] [Abstract][Full Text] [Related]
7. Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations--a short review.
Mohamed Ali S; Chia SE
Ind Health; 2008 Aug; 46(4):309-17. PubMed ID: 18716378
[TBL] [Abstract][Full Text] [Related]
8. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
Furlong CE
J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
[TBL] [Abstract][Full Text] [Related]
9. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
[TBL] [Abstract][Full Text] [Related]
10. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
Costa LG; Giordano G; Cole TB; Marsillach J; Furlong CE
Toxicology; 2013 May; 307():115-22. PubMed ID: 22884923
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
Walker K; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):440-72. PubMed ID: 20183529
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
[TBL] [Abstract][Full Text] [Related]
14. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population.
Cataño HC; Cueva JL; Cardenas AM; Izaguirre V; Zavaleta AI; Carranza E; Hernández AF
Environ Mol Mutagen; 2006 Dec; 47(9):699-706. PubMed ID: 17078098
[TBL] [Abstract][Full Text] [Related]
15. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
Cole TB; Jansen K; Park S; Li WF; Furlong CE; Costa LG
Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
Albers JW; Garabrant DH; Berent S; Richardson RJ
J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
[TBL] [Abstract][Full Text] [Related]
17. Bayesian meta-analysis of inter-phenotypic differences in human serum paraoxonase-1 activity for chemical risk assessment.
Darney K; Kasteel EEJ; Buratti FM; Turco L; Vichi S; Béchaux C; Roudot AC; Kramer NI; Testai E; Dorne JLCM; Di Consiglio E; Lautz LS
Environ Int; 2020 May; 138():105609. PubMed ID: 32114288
[TBL] [Abstract][Full Text] [Related]
18. Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status.
Jarvik GP; Jampsa R; Richter RJ; Carlson CS; Rieder MJ; Nickerson DA; Furlong CE
Pharmacogenetics; 2003 May; 13(5):291-5. PubMed ID: 12724622
[TBL] [Abstract][Full Text] [Related]
19. The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.
Ginsberg G; Smolenski S; Neafsey P; Hattis D; Walker K; Guyton KZ; Johns DO; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):307-33. PubMed ID: 20183525
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
Costa LG; Richter RJ; Li WF; Cole T; Guizzetti M; Furlong CE
Biomarkers; 2003; 8(1):1-12. PubMed ID: 12519632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
